BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

434 related articles for article (PubMed ID: 9398179)

  • 1. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
    Plotnick MI; Schechter NM; Wang ZM; Liu X; Rubin H
    Biochemistry; 1997 Nov; 36(47):14601-8. PubMed ID: 9398179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.
    Chaillan-Huntington CE; Gettins PG; Huntington JA; Patston PA
    Biochemistry; 1997 Aug; 36(31):9562-70. PubMed ID: 9236002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigating serpin-enzyme complex formation and stability via single and multiple residue reactive centre loop substitutions in heparin cofactor II.
    Sutherland JS; Bhakta V; Sheffield WP
    Thromb Res; 2006; 117(4):447-61. PubMed ID: 15869786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the P2 residue in determining the specificity of serpins.
    Djie MZ; Le Bonniec BF; Hopkins PC; Hipler K; Stone SR
    Biochemistry; 1996 Sep; 35(35):11461-9. PubMed ID: 8784202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of serpin inhibitory function by mutagenesis of ovalbumin and generation of chimeric ovalbumin/PAI-2 fusion proteins.
    McCarthy BJ; Worrall DM
    J Mol Biol; 1997 Apr; 267(3):561-9. PubMed ID: 9126838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
    Bottomley SP; Lawrenson ID; Tew D; Dai W; Whisstock JC; Pike RN
    Protein Sci; 2001 Dec; 10(12):2518-24. PubMed ID: 11714919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
    Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
    J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of alpha 1-antichymotrypsin into a human neutrophil elastase inhibitor: demonstration of variants with different association rate constants, stoichiometries of inhibition, and complex stabilities.
    Rubin H; Plotnick M; Wang ZM; Liu X; Zhong Q; Schechter NM; Cooperman BS
    Biochemistry; 1994 Jun; 33(24):7627-33. PubMed ID: 8011628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibitory specificity of human proteinase inhibitor 8 is expanded through the use of multiple reactive site residues.
    Dahlen JR; Foster DC; Kisiel W
    Biochem Biophys Res Commun; 1998 Mar; 244(1):172-7. PubMed ID: 9514892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering an anion-binding cavity in antichymotrypsin modulates the "spring-loaded" serpin-protease interaction.
    Lukacs CM; Rubin H; Christianson DW
    Biochemistry; 1998 Mar; 37(10):3297-304. PubMed ID: 9521649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory plant serpins with a sequence of three glutamine residues in the reactive center.
    Hejgaard J
    Biol Chem; 2005 Dec; 386(12):1319-23. PubMed ID: 16336127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of reactive site location on the inhibitory properties of the serpin alpha(1)-antichymotrypsin.
    Plotnick MI; Rubin H; Schechter NM
    J Biol Chem; 2002 Aug; 277(33):29927-35. PubMed ID: 12055188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations.
    Huntington JA; Fan B; Karlsson KE; Deinum J; Lawrence DA; Gettins PG
    Biochemistry; 1997 May; 36(18):5432-40. PubMed ID: 9154925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein engineering of chimeric Serpins: an investigation into effects of the serpin scaffold and reactive centre loop length.
    Bottomley SP; Stone SR
    Protein Eng; 1998 Dec; 11(12):1243-7. PubMed ID: 9930674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of trypsins by insect peptides: role of P6-P10 loop.
    Kellenberger C; Ferrat G; Leone P; Darbon H; Roussel A
    Biochemistry; 2003 Nov; 42(46):13605-12. PubMed ID: 14622007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
    Apostoluk W; Otlewski J
    Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.